Central Nervous System Agents in Medicinal Chemistry
Title:Preface:
Volume: 16 Issue: 1
Author(s): Gregory S. Hamilton
Affiliation:
Export Options
About this article
Cite this article as:
S. Hamilton Gregory, Preface:, Central Nervous System Agents in Medicinal Chemistry 2016; 16 (1) . https://dx.doi.org/10.2174/187152491601151104094846
DOI https://dx.doi.org/10.2174/187152491601151104094846 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
24
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacology of the Intracellular Pathways Activated by Amyloid Beta Protein
Mini-Reviews in Medicinal Chemistry Neurocognitive and Psychiatric Markers for Addiction: Common vs. Specific Endophenotypes for Heroin and Amphetamine Dependence
Current Topics in Medicinal Chemistry Affordable Antiretroviral Drugs for the Under-Served Markets: How to Expand Equitable Access Against the Backdrop of Challenging Scenarios?
Current HIV Research Reduction in the Ratio of Low-density Lipoprotein Cholesterol to Highdensity Lipoprotein Cholesterol is Associated with Increased Risks of Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
Current Neurovascular Research Antioxidant Activity of Resveratrol Analogs
Letters in Drug Design & Discovery Recent Medicinal Chemistry Studies for Multitarget Agents-Part II
Current Drug Targets In Search of Reward Deficiency Syndrome (RDS)-Free Controls: The “Holy Grail” in Genetic Addiction Risk Testing
Current Psychopharmacology Targeting Neuronal Nicotinic Receptors: a Path to New Therapies
Current Drug Targets - CNS & Neurological Disorders Tau Truncation is a Productive Posttranslational Modification of Neurofibrillary Degeneration in Alzheimer’s Disease
Current Alzheimer Research Molecular Mechanisms of Bioprotection Process by Trehalose
Current Nutrition & Food Science Burkholderia mallei and Burkholderia pseudomallei: The Causative Micro-organisms of Glanders and Melioidosis
Recent Patents on Anti-Infective Drug Discovery Preface:
Central Nervous System Agents in Medicinal Chemistry Risk Factors for Lung Cancer in Never Smokers: A Recent Review Including Genetics
Current Respiratory Medicine Reviews Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design Diversity of Molecular Factors in Alzheimer’s Disease
Current Alzheimer Research Quetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind,Placebo-Controlled Study
Current Alzheimer Research Polyunsaturated Fatty Acids and Neurological Diseases
Mini-Reviews in Medicinal Chemistry Disturbed Sleep Patterns in Elders with Mild Cognitive Impairment: The Role of Memory Decline and ApoE ε 4 Genotype
Current Alzheimer Research Neuropsychological Aspects of Dual Diagnosis
Current Drug Abuse Reviews